NATIONAL BANK OF CANADA /FI/ - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$187
-4.6%
3400.0%0.00%
Q2 2023$196
-17.6%
3400.0%0.00%
Q1 2023$238
-68.9%
3400.0%0.00%
Q4 2022$765
-23.5%
3400.0%0.00%
Q3 2022$1,0000.0%3400.0%0.00%
Q2 2022$1,000
-50.0%
3400.0%0.00%
Q1 2022$2,000
-60.0%
3400.0%0.00%
Q4 2021$5,0003400.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders